In vivo and in vitro evaluation of the mutagenic potential of carbamazepine: Does melatonin have anti-mutagenic activity?

Toxicology

Volumn 125, Issue 1, 1998, Pages 45-52

  Awara, Wageh M ^a   El Gohary, Mona ^a   El Nabi, Sobhi H ^b   Fadel, Wael A ^a  

^a TANTA UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Carbamazepine; Chromosome aberrations; Melatonin; Mutagenicity; Sister chromatid exchanges

Indexed keywords

ANTIMUTAGENIC AGENT; CARBAMAZEPINE; MELATONIN;

ADULT; ARTICLE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EPILEPSY; FEMALE; GENOTOXICITY; HORMONE ACTION; HUMAN; LYMPHOCYTE; MALE; MITOSIS INDEX; MUTAGENICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MELATONIN; MUTAGENICITY TESTS; SISTER CHROMATID EXCHANGE;

EID: 0032536118     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00160-1     Document Type: Article

References (26)

1. Blickenstaff R.T., Brandstandter S.M., Reddy S., Witt R. Potential radioprotective agents. Homologs of melatonin. J. Pharm. Sci. 83:1994;216-218.
2. Dulout F.N., Olivero O.A. Anaphase, telophase analysis of chromosomal damage induced chemicals. Environ. Mutagenesis. 6:1984;299-310.
3. Ehrenberg L., Hussain S. Genetic toxicity of some important epoxides. Mutation Res. 86:1981;1-13.
4. Flejter W.L., Astemborski J.A., Hassel T.M., Cohen M.M. Cytogenetic effects of phenytoin and/or carbamazepine on human peripheral leukocytes. Epilepsia. 30(3):1989;374-379.
5. Frigeiro A., Morselli P.L. Carbamazepine: biotransformation. Adv. Neurol. 11:1975;295-308.
6. Glatt H.R., Oesch A., Frigeiro A., Garattini S. Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. Differences in mutagenicity. Int. J. Cancer. 16:1975;787-797.
7. Goyle S., Maurya A.K., Kailash S., Maheshwari M.C. Mutagenic risk in epileptic patients before and after anticonvulsant therapy. Epilepsia. 28(1):1987;81-86.
8. Guenguerich F.P. Characterization of microsomal cytochrome P-450 enzymes. Annu. Rev. Pharmacol. Toxicol. 29:1989;241-264.
9. Herha J., Obe G. Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin. Hum. Genet. 34:1976;255-263.
10. Janiaud P. Light, pineal, melatonin and chemical carcinogenesis. Neuroendocrinol. Lett. 9:1987;311.
11. Lamberti L.P., Bigatti P., Ardito G. Cell kinetic and sister chromatid exchange frequency in human lymphocytes. Mutation Res. 120:1983;193-199.
12. Lertratanangkoon K., Horning G. Metabolism of carbamazepine. Drug Metab. Dispos. 10:1982;1-10.
13. Menendez-Pelaez A., Reiter R.J. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J. Pineal Res. 15:1993;59-69.
14. Moorhead P.S., Nowell P.C., Mellman W.J., Battips D.M., Hungerford D.A. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell Res. 20:1960;613-616.
15. Perry P., Wolff S. New Giemsa method for the differential-staining of sister chromatids. Nature (London). 251:1974;156-158.
16. Persengiev S.P., Kyurkchiev S. Selective effect of melatonin on the proliferation of lymphoid cells. Int. J. Biochem. 25:1993;441-444.
17. Reiter R.J. Melatonin: that ubiquitously acting pineal hormone. News Physiol. Sci. 6:1991;223-227.
18. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev. 12:1991;151-180.
19. Riad L.E., Sawchuk R.J. Simultaneous determination of carbamazepine and its epoxide and transdiol metabolites in plasma by microbore liquid chromatography. Clin. Chem. 34:1988;1863-1866.
20. Schaumann B., Satish J., Johnson S.B., Moore K., Cervenka J. Effects of carbamazepine on human chromosomes. Epilepsia. 26(4):1985;346-352.
21. Shapiro S.D., Slone S.C., Hartz L. et al. Anticonvulsants and parentral epilepsy in the development of birth defects. Lancet. i:1976;272-275.
22. Sinues B., Gazulla J., Bernal M.L., Lanuza J., Fanlo A., Sacnz M.A., Bartolome M. Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia. Mutation Res. 334:1995;259-265.
23. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:1993;57-60.
24. Vijayalaxmi, Reiter R.J., Meltz M.L. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutation Res. 346:1995;23-31.
25. Vijayalaxmi, Reiter R.J., Leal B.Z., Meltz M.L. Effects of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human brood lymphocytes. Mutation Res. 351:1996;187-192.
26. Waldhauser F., Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann. NY Acad. Sci. 453:1985;205-214.